We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSBK icon
3101
Timberland Bancorp
TSBK
$353M
-12,087
Closed -$336K
UBFO
3102
DELISTED
United Security Bancshares
UBFO
-22,534
Closed -$185K
UBX
3103
DELISTED
Unity Biotechnology
UBX
-3,736
Closed -$224K
ULBI icon
3104
Ultralife
ULBI
$88.3M
-11,129
Closed -$92K
UNTY icon
3105
Unity Bancorp
UNTY
$602M
-12,720
Closed -$280K
UTI icon
3106
Universal Technical Institute
UTI
$1.52B
-26,060
Closed -$152K
VERO
3107
DELISTED
Venus Concept
VERO
-99
Closed -$38K
VNRX icon
3108
VolitionRx Ltd
VNRX
$9.4M
-946
Closed -$71K
VYGR icon
3109
Voyager Therapeutics
VYGR
$189M
-33,868
Closed -$160K
YARW
3110
Yarrow Bioscience, Inc. Common Stock
YARW
$110M
-54
Closed -$332K
WEYS icon
3111
Weyco Group
WEYS
$411M
-10,039
Closed -$217K
WHG icon
3112
Westwood Holdings Group
WHG
$184M
-13,714
Closed -$198K
WLFC icon
3113
Willis Lease Finance
WLFC
$1.37B
-14,361
Closed -$208K
WNEB icon
3114
Western New England Bancorp
WNEB
$282M
-39,612
Closed -$334K
XCUR icon
3115
Exicure
XCUR
$8.73M
-291
Closed -$95K
XERS icon
3116
Xeris Biopharma Holdings
XERS
$1.24B
-41,774
Closed -$188K
XFOR icon
3117
X4 Pharmaceuticals
XFOR
$390M
-688
Closed -$178K
ARQ icon
3118
Arq
ARQ
$90.1M
-29,387
Closed -$162K
AIOT
3119
PowerFleet Inc
AIOT
$556M
-33,176
Closed -$273K
PVLA
3120
Palvella Therapeutics
PVLA
$2.2B
-786
Closed -$162K
EVBN
3121
DELISTED
Evans Bancorp Inc
EVBN
-7,830
Closed -$265K
ENZ
3122
DELISTED
Enzo Biochem, Inc.
ENZ
-75,155
Closed -$259K
TBNK
3123
DELISTED
Territorial Bancorp Inc.
TBNK
-12,924
Closed -$342K
IVAC
3124
DELISTED
Intevac Inc
IVAC
-26,331
Closed -$188K
SBT
3125
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
-29,391
Closed -$166K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.